When Evidence Gap Becomes a Commercial Liability
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage.
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage.
Which EHR vendors were the hottest across the globe? The KLAS "Global EMR Market Share 2017" report analyzes new hospital EHR contracts that happened all over the world in 2016.